These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18408892)

  • 21. Intracerebral hemorrhage as initial symptom of a brain tumor.
    Padt JP; De Reuck J; Eecken H vander
    Acta Neurol Belg; 1973; 73(4):241-51. PubMed ID: 4358767
    [No Abstract]   [Full Text] [Related]  

  • 22. Supratentorial glioblastoma multiforme and infratentorial ependymoma with repeated hemorrhages.
    Shuangshoti S; Dharmmaponpilas J
    J Med Assoc Thai; 1978 Aug; 61(8):489-96. PubMed ID: 211175
    [No Abstract]   [Full Text] [Related]  

  • 23. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 26-1990. A 68-year-old man with a right hemiparesis, abulia, and multiple intracerebral hemorrhages.
    N Engl J Med; 1990 Jun; 322(26):1866-78. PubMed ID: 2161497
    [No Abstract]   [Full Text] [Related]  

  • 24. Glioblastoma Secondary to Meningioma: A Case Report and Literature Review.
    Sahuc P; Joubert C; Nguyen AT; Fouet B; Wybrecht D; Faivre A; Alla P; Dagain A
    World Neurosurg; 2017 Feb; 98():881.e9-881.e13. PubMed ID: 27867119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
    Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reoxygenation of glioblastoma multiforme treated with fractionated radiotherapy concomitant with temozolomide: changes defined by 18F-fluoromisonidazole positron emission tomography: two case reports.
    Narita T; Aoyama H; Hirata K; Onodera S; Shiga T; Kobayashi H; Murata J; Terasaka S; Tanaka S; Houkin K
    Jpn J Clin Oncol; 2012 Feb; 42(2):120-3. PubMed ID: 22198964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temozolomide and other potential agents for the treatment of glioblastoma multiforme.
    Nagasawa DT; Chow F; Yew A; Kim W; Cremer N; Yang I
    Neurosurg Clin N Am; 2012 Apr; 23(2):307-22, ix. PubMed ID: 22440874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Streaming hypointensity in hemorrhagic glioblastoma multiforme. An illustrative case.
    Ragland RL; Wagner LD; Huang YP; Som PM; Teal JS; Handler MS
    Neuroradiology; 1990; 32(3):241-3. PubMed ID: 2170861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temozolomide (Temodal) for treatment of primary brain tumours.
    MacConnachie AM
    Intensive Crit Care Nurs; 2000 Feb; 16(1):59-60. PubMed ID: 10790718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concomitant radiochemotherapy in a patient with multiple sclerosis and glioblastoma.
    Oberndorfer S; Ruzin PC; Grisold W
    Clin Neuropathol; 2008; 27(5):346-50. PubMed ID: 18808066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiotherapy plus temozolomide in elderly patients with glioblastoma: a "real-life" report.
    Biau J; Chautard E; De Schlichting E; Dupic G; Pereira B; Fogli A; Müller-Barthélémy M; Dalloz P; Khalil T; Dillies AF; Durando X; Godfraind C; Verrelle P
    Radiat Oncol; 2017 Dec; 12(1):197. PubMed ID: 29212499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A concurrent ultra-fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma.
    Beauchesne P; Quillien V; Faure G; Bernier V; Noel G; Quetin P; Gorlia T; Carnin C; Pedeux R
    Int J Cancer; 2016 Mar; 138(6):1538-44. PubMed ID: 26501997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance status during and after radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiforme.
    Lee JH; Jung TY; Jung S; Kim IY; Jang WY; Moon KS; Jeong EH
    J Clin Neurosci; 2013 Apr; 20(4):503-8. PubMed ID: 23313530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ganglioglioma occurring with glioblastoma multiforme: separate lesions or the same lesion?
    Stevens QE; Howes G; Dickerman RD; Lee JM; Nardone EM
    Clin Neurol Neurosurg; 2007 Feb; 109(2):195-9. PubMed ID: 17056178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple bone metastases from glioblastoma multiforme without local brain relapse: a case report and review of the literature.
    Takanen S; Bangrazi C; Caiazzo R; Raffetto N; Tombolini V
    Tumori; 2013; 99(5):e237-40. PubMed ID: 24362877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Six year survival after prolonged temozolomide treatment in a 30-year-old patient with glioblastoma.
    Poelen J; Prick MJ; Jeuken JW; Wesseling P; Bernsen HJ
    Acta Neurol Belg; 2009 Sep; 109(3):238-42. PubMed ID: 19902821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal metastasis of glioblastoma multiforme before gliosarcomatous transformation: a case report.
    Hsu BH; Lee WH; Yang ST; Han CT; Tseng YY
    BMC Neurol; 2020 May; 20(1):178. PubMed ID: 32393192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide.
    Saito T; Sugiyama K; Ikawa F; Yamasaki F; Ishifuro M; Takayasu T; Nosaka R; Nishibuchi I; Muragaki Y; Kawamata T; Kurisu K
    World Neurosurg; 2017 Jan; 97():21-26. PubMed ID: 27693246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy.
    Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Yamaguchi S; Tanino M; Murata J; Houkin K
    Brain Tumor Pathol; 2013 Apr; 30(2):67-72. PubMed ID: 22752663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MGMT promoter methylation correlates with survival benefit and sensitivity to temozolomide in pediatric glioblastoma.
    Donson AM; Addo-Yobo SO; Handler MH; Gore L; Foreman NK
    Pediatr Blood Cancer; 2007 Apr; 48(4):403-7. PubMed ID: 16609952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.